Novel fluorescent tracer agents, transdermal sensor innovations and unique analytical approaches are focused on providing tools to help physicians decrease the burden of chronic diseases.
The MediBeacon intellectual property portfolio includes granted composition of matter, device, algorithm, process and method patents in the US, Europe and globally.